Cite
HARVARD Citation
Chaparro, M. et al. (2019). Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial. Therapeutic advances in gastroenterology. p. . [Online].